Product Information
XARELTO 20 MG TABLET is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $19.5419 per EA under NDC 50458057930. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jul 1, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the rivaroxaban market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/1
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458057930
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
RIVAROXABANApproval Type
New Drug (NDA)
FDA Application
NDA022406FDA Approved
7/1/2011
TE Code
AB
On Market Since
11/5/2011
Pharmacological Classes
Price Statistics
The NADAC for XARELTO 20 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 124.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.5419 per EA |
|---|---|
| All-time high | $19.5643 (Jun 10, 2026) |
| All-time low | $8.6922 (Nov 28, 2013) |
| 52-week high | $19.5643 |
| 52-week low | $19.1053 |
| Median price | $15.0325 |
| Average price | $14.6705 |
| Largest weekly change | +9.9% (Dec 10, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Janssen Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
rivaroxaban market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Factor Xa Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of XARELTO 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for XARELTO 20 MG TABLET, manufactured by Janssen Pharmaceuticals Inc., is $19.5419 per EA (NDC 50458057930), effective Sep 30, 2026.
How has the price of XARELTO 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for XARELTO 20 MG TABLET has risen 124.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for XARELTO 20 MG TABLET?
Since Nov 28, 2013, the NADAC for XARELTO 20 MG TABLET has ranged from a low of $8.6922 (Nov 28, 2013) to a high of $19.5643 (Jun 10, 2026), with a median of $15.0325 per EA.
Are there cheaper alternatives to XARELTO 20 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as XARELTO 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures XARELTO 20 MG TABLET?
XARELTO 20 MG TABLET (NDC 50458057930) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.